Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

NOVAVAX INC Director's Dealing 2021

Aug 18, 2021

31982_dirs_2021-08-18_71626df3-d4d2-4f8a-b626-a46e424eb201.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2021-08-16

Reporting Person: Kelly James Patrick (EVP, CFO and Treasurer)

More from NOVAVAX INC

Regulatory Filings 2026
May 6
Interim / Quarterly Report 2026
May 6
Annual Report 2026
Apr 27
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Regulatory Filings 2026
Feb 26
Annual Report 2026
Feb 26
Director's Dealing 2026
Jan 26
View all filings →